Skip to main content
RecallFDAfda-F-1146-2019MISLABELED

Good Neighbor Pharmacy, Co Q10 200mg Capsule, Dietary Supplement, UPC: 0-87701-40817-5, 30 capsules.

Category
Units Affected
5,484
Recall Date
January 22, 2019
Issuing Agency
Hazard
Mislabeled

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1146-2019.

21st Century HealthCare, Inc. is recalling Good Neighbor Pharmacy brand Co Q10 200mg 30ct capsules due the product being mislabeled and potentially containing Vit D 2000 IU.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1146-2019.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Twenty-first Century Healthcare, Inc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1146-2019.

Twenty-First Century Healthcare, Inc

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Twenty-first Century Healthcare, Inc Recall FAQ

Twenty-first Century Healthcare, Inc is the subject of a supplements safety report: Good Neighbor Pharmacy, Co Q10 200mg Capsule, Dietary Supplement, UPC: 0-87701-40817-5, 30 capsules.. The notice was published on January 22, 2019 by the U.S. Food and Drug Administration (FDA). Approximately 5,484 units are potentially affected.